You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: May 21, 2025

Drug Sales Trends for OXYCONTIN


✉ Email this page to a colleague

« Back to Dashboard


Payment Methods and Pharmacy Types for OXYCONTIN (2021)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $24,019,634
INSIDE ANOTHER STORE $377,723,837
[disabled in preview] $360,412,865
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 57,875
INSIDE ANOTHER STORE 445,955
[disabled in preview] 939,932
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $52,097,804
MEDICARE $406,148,597
[disabled in preview] $303,909,935
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for OXYCONTIN
Drug Units Sold Trends for OXYCONTIN

Annual Sales Revenues and Units Sold for OXYCONTIN

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2021
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2020
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2019
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2018
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2017
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2016
OXYCONTIN ⤷  Try for Free ⤷  Try for Free 2015
>Drug Name >Revenues (USD) >Units >Year

Oxycodone (OxyContin) Market Analysis and Sales Projections

Introduction to Oxycodone (OxyContin)

Oxycodone, commonly known by the brand name OxyContin, is a potent opioid medication used for the management of moderate to severe pain. The drug has been a cornerstone in pain management but has also been at the center of the opioid crisis due to its potential for misuse and addiction.

Market Size and Growth Projections

The global oxycodone market is anticipated to experience significant growth over the next decade. Here are some key projections:

  • Current Market Size: The oxycodone market was valued at approximately US$ 5.11 billion in 2023[2].
  • Projected Growth: The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 5.7% from 2023 to 2033, reaching a valuation of US$ 8.92 billion by 2033[2].
  • Alternative Projections: Another report suggests a CAGR of 5.8% from 2023 to 2030, driven by increasing demand for effective pain management solutions and the rising prevalence of chronic diseases[3].

Drivers of Market Growth

Several factors are driving the growth of the oxycodone market:

Increasing Demand for Pain Management

The escalating demand for efficient pain management remedies is a primary driver. Oxycodone is widely prescribed for post-surgery pain, chronic pain conditions such as arthritis and cancer, and other severe pain scenarios[2][3].

Rising Prevalence of Chronic Diseases

The increasing prevalence of chronic diseases like Parkinson's disease, rheumatoid arthritis, and cancer is contributing to the growth. For instance, the Parkinson's Foundation reports that about 1 million people in the United States are living with Parkinson's disease, and these patients often require long-acting oxycodone treatment[2].

Aging Population

The global aging population is another significant factor. As people age, conditions like osteoarthritis and associated chronic pain become more prevalent, leading to an increased demand for oxycodone drugs[3].

Regional Market Analysis

North America

North America dominates the oxycodone market, driven by the high prevalence of chronic pain, cancer, and arthritis. The United States, in particular, is expected to maintain its leadership due to its substantial healthcare expenditure and the rising prevalence of chronic diseases[2][3].

Europe

Europe is another significant region, with countries like Germany, the UK, France, Italy, and Spain contributing to the market growth. The region's market is driven by similar factors, including the increasing burden of chronic pain diseases and the aging population[1].

Asia Pacific

The Asia Pacific region is also expected to see significant growth, driven by the increasing demand for pain management solutions in countries like China, Japan, India, and Australia. The growing elderly population and the rising incidence of chronic diseases in this region are key drivers[1].

Latin America and Middle East & Africa

These regions are expected to grow at a slower pace but still contribute to the overall market expansion. Factors such as improving healthcare infrastructure and increasing awareness about pain management are driving the growth in these regions[1].

Distribution Channels and Routes of Administration

Distribution Channels

Hospital pharmacies account for the largest share of the oxycodone market, followed by retail pharmacies and online pharmacies. The convenience and accessibility of these channels play a crucial role in the market's growth[1].

Routes of Administration

Oxycodone is administered primarily through oral and parenteral routes. The oral route is more common, but there is a growing interest in developing new delivery methods such as oxycodone patches and nasal sprays to improve pain relief and reduce the risk of abuse[2].

Challenges and Regulatory Environment

Opioid Crisis and Regulatory Interventions

The oxycodone market faces significant challenges due to the opioid crisis. Regulatory interventions aimed at curbing opioid abuse, such as stricter prescribing practices and monitoring programs, have impacted the market. For example, the reformulation of OxyContin in 2010 led to a shift towards illicit drug use in some regions, resulting in increased rates of infectious diseases and overdose deaths[4].

Impact of Marketing Practices

Historical marketing practices have had long-term effects on the market. A Yale study found that aggressive marketing of OxyContin in the past led to increased rates of overdose deaths, hepatitis diagnoses, and deaths from infective endocarditis in states with higher marketing exposure[4].

Key Strategies by Market Players

Market players are adopting several strategies to maintain their position and grow in the market:

Development of New Delivery Methods

Companies are focusing on developing new delivery methods for oxycodone, such as patches and nasal sprays, which offer faster onset of action, improved pain relief, and reduced risk of abuse[2].

Regulatory Compliance

Ensuring compliance with changing regulatory requirements is crucial. Market players are adapting to stricter prescribing practices and monitoring programs to ensure access for patients while preventing misuse[2].

Market Attractiveness Analysis

The market attractiveness analysis highlights the regions, types, routes of administration, and distribution channels that offer the most potential for growth. North America and Europe are currently the most attractive regions due to their high demand for pain management solutions and well-established healthcare systems[1].

Key Takeaways

  • The global oxycodone market is projected to grow significantly, driven by increasing demand for pain management solutions and the rising prevalence of chronic diseases.
  • North America and Europe are the dominant regions, with the United States leading due to its substantial healthcare expenditure.
  • The market faces challenges from the opioid crisis and regulatory interventions, but new delivery methods and compliance strategies are helping market players navigate these issues.
  • The aging population and increasing awareness about pain management are additional drivers of market growth.

FAQs

What is the current market size of the oxycodone market?

The oxycodone market was valued at approximately US$ 5.11 billion in 2023[2].

What is the projected growth rate of the oxycodone market?

The market is expected to grow at a CAGR of 5.7% from 2023 to 2033[2].

Which region dominates the oxycodone market?

North America, particularly the United States, dominates the oxycodone market due to its high prevalence of chronic pain and substantial healthcare expenditure[2][3].

What are the main drivers of the oxycodone market growth?

The main drivers include the increasing demand for pain management solutions, the rising prevalence of chronic diseases, and the growing aging population[2][3].

How has the opioid crisis impacted the oxycodone market?

The opioid crisis has led to stricter regulatory interventions, changes in prescribing practices, and a shift towards illicit drug use in some regions, affecting the market's growth and dynamics[4].

What new delivery methods are being developed for oxycodone?

New delivery methods such as oxycodone patches and nasal sprays are being developed to offer faster onset of action, improved pain relief, and reduced risk of abuse[2].

Last updated: 2024-12-30

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.